Tech Company Financing Transactions
Regenesis Biomedical Funding Round
Solstice Capital, private investors and Valley Ventures participated in a $2.8 million venture round for Regenesis Biomedical. The funding round was announced on 6/30/2008.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$2,788,300
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5301 N. Pima Rd.
Scottsdale, AZ 85250
USA
Scottsdale, AZ 85250
USA
Phone
Website
Email Address
Overview
Regenesis Biomedical, Inc. developed and markets the Provant Wound Therapy System, the exciting new scientifically proven approach that is redefining the care of soft tissue wounds.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Brooks
Chief Financial Officer
Dennis Genge
VP - Marketing
Scott Robey
VP - Sales
Thomas Eisiminger
Browse more venture capital transactions:
Prev: 6/30/2008: SmartDrive Systems venture capital transaction
Next: 6/30/2008: OmniPV venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs